RenaissanceRe (RNR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
17 Apr, 2026Strategic evolution and growth
Achieved significant scale and diversification through acquisitions, notably Validus in 2023 and Tokio Millennium Re in 2019, expanding presence in key global markets.
Enhanced business model with increased contributions from fee and investment income, reducing reliance on underwriting alone.
Proprietary risk intelligence and technology, including REMS and RenaissanceRe Risk Sciences, support superior risk selection and pricing.
Capital Partners business manages $13.0B in third-party capital, deepening risk-matching capabilities.
Consistent capital management with strategic share repurchases and a 31-year record of dividend increases.
Financial performance and profitability
Reported $2.6B net income and $1.9B operating income available to common shareholders in 2025.
Return on average common equity reached 25.9%, with operating ROACE at 18.2%.
Combined ratio improved to 87.2% in 2025, reflecting disciplined underwriting.
Gross premiums written totaled $11.7B, with a balanced portfolio across property, casualty, and specialty lines.
Book value per share grew to $247.00, with tangible book value per share plus accumulated dividends at $259.78.
Three drivers of profit and risk management
Underwriting, fee, and net investment income are additive, reducing earnings volatility and enhancing returns.
Fee and retained net investment income contributed 15 points to ROACE in 2025, up 4x since 2021.
Managed $36.1B in total investments, with a conservative, diversified portfolio and 2.5x investment leverage.
Capital Partners vehicles span rated and collateralized structures, supporting efficient capital deployment.
Demonstrated resilience and profitability despite rising industry catastrophe losses.
Latest events from RenaissanceRe
- Approval of a new long-term incentive plan is sought to support growth and align interests.RNR
Proxy filing10 Apr 2026 - Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Net income hit $2.65B in 2025, with 30.8% book value growth despite major loss events.RNR
Q4 20254 Feb 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026 - Q3 net income soared to $1.17B, with strong premium growth and investment gains.RNR
Q3 202415 Jan 2026 - Record $2.2B operating income and 26% tangible book value growth despite catastrophe losses.RNR
Q4 20249 Jan 2026 - Catastrophe losses led to an operating loss, but investment gains and capital strength persisted.RNR
Q1 202520 Dec 2025 - 2024 saw record growth, strategic integration, and enhanced governance, with all proposals recommended for approval.RNR
Proxy Filing2 Dec 2025